Skip to content

Effect of Silybum marianum extract on hot flash symptoms in postmenopausal women

Evaluation the effect of a preparation from of Silybum marianum on hot flashes in postmenopausal women

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190223042811N1
Enrollment
80
Registered
2019-06-03
Start date
2019-01-05
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hot flashes. Menopausal and female climacteric states

Interventions

Intervention 1: Intervention group: capsules containing 250 mg of fruit extract "silybum marianum" twice a day for 8 weeks. Intervention 2: Control group: capsules containing 250 mg of starch powder t

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged 40 to 60 years old. 3 times daily from a previous month. Individuals who have been treated at least People who are at least 12 and at most 60 months have passed since the last month. (Menopause) FSH>40

Exclusion criteria

Exclusion criteria: Use smoking, Valkel cigarettes. People with underlying diseases (liver, kidney, metabolic disorders such as thyroid problems) are. They have a history of sensitivity to herbal medicines. People who have a history of using anxiolytics, antidepressant, estrogen and progesterone hormones in the last 6 months, use anticoagulant and anti-inflammatory drugs like ibuprofen and other drugs affecting hot flashes. People who have a history of asthma and allergies. Pathologic and ultrasonography have been reported in the uterus. Have a history of mass or malignancy in the breast, ovary or uterus. Do not have natural blood pressure. Have a history of thromboembolism.

Design outcomes

Primary

MeasureTime frame
Hot flashes. Timepoint: At the beginning of treatment, weeks 4 and 8 during treatment and 4 weeks after treatment. Method of measurement: The standard GREEN questionnaire, HFRDIS.;The frequency of hot flashes. Timepoint: At the beginning of treatment, weeks 4 and 8 during treatment and 4 weeks after treatment. Method of measurement: Daily Inventory of Hot flashes.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZohreh Saberi

Babol University of Medical Sciences

Zohrehsaberi90@gmail.com+98 11 3219 4728

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026